Approval · Notice of Compliance 4607 · 1996
AREDIA: Notice of Compliance 4607
Issued May 27, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4607
- Date
- May 27, 1996
- Company
- Ciba-Geigy Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: lystic bone metastases and multiple myeloma
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AREDIA | Not yet assigned | — |
Medicinal ingredients
- PAMIDRONATE DISODIUM 30 MG per VIAL
- PAMIDRONATE DISODIUM 60 MG per VIAL
- PAMIDRONATE DISODIUM 90 MG per VIAL